Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydromorphone for Perioperative Analgesia in Lung Tumor Ablation Parallel Controlled ：A Randomized, Parallel Controlled Trial

NCT05848635 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.

NCT NCT05848635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05848635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydromorphone for Perioperative Analgesia in Lung Tumor Ablation Parallel Controlled ：A Randomized, Parallel Controlled Trial
Lead sponsor
Qianfoshan Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
May 1, 2023
Completion date
May 1, 2024
Enrollment
88 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ablation, pulmonary nodule